ABOUT PHENYLEPHRINE HYDROCHLORIDE

In the study in breast cancer cells, the combination of lapatinib, a dual HER2/neu and EGFR tyrosine kinase inhibitor, with INK128 prevented both HER2 and HER3 phosphorylation induced by INK128 and developed synergistic induction of mobile death in various HER2-good mobile lines proof against trastuzumab and lapatinib. In vivoBelamarine(2016) Treha